Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine dose comparison versus acetaminophen in knee osteoarthritis
IRCT20260722070302N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of duloxetine and acetaminophen in knee osteoarthritis (OA) (3 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoints: Pain severity, Knee joint function and 2 more. Started Aug 2026; status: completed.
02
Drugs
duloxetineacetaminophen
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20260722070302N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260722070302N1.